Craneware issued an update on trading for the year ended 30 June 2024. The Group expects to deliver an adjusted EBITDA of at least $58 million, a 6% increase over the prior year, and towards the top end of market expectations. Revenue is expected to exceed $188 million, which is above the upper end of current market expectations, an 8% increase over the prior year.
The Group said the ongoing investment in the Trisus platform has delivered a good sales performance in the year and, combined with partner programs, it has delivered significant returns to the US healthcare provider customer base.
Craneware will announce its results for the year ended 30 June 2024 on 3 September 2024.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback: editorial@rttnews.com